ClinicalTrials.Veeva

Menu

Incidence of Dual Mobility Polyethylene Wear in Total Hip Prosthesis. Randomised Study Versus Fixed Insert by Radiostereometric Analysis. (DOUMOB)

C

Caen University Hospital

Status

Completed

Conditions

Total Hip Replacement

Treatments

Device: Novae E®
Device: Sunfit®
Device: Quartz®

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The total hip replacement, with over 120,000 cases per year in France, provides short term, excellent functional results and a significant improvement in quality of life, in almost all cases. However, observation showed that the dislocation is not a rare complication (2-4%) and the lifetime of the implants is limited due to aseptic loosening.

The evaluation process used in this study will be the extent of penetration of the metal femoral head in the cup and micro mobility metal back by radiostereometric analysis (RSA) whose precision provides early results (2 3 years), long before wear and migration are measurable by conventional radiological means. The main objective will be to compare, 2 years after the intervention, the penetration of the metal femoral head in 3 types of inserts: two dual mobility inserts, one at tripod attachment (Novae E®), the other press fit pure (Sunfit®), and a fixed insert (Quartz®).

This is a randomized controlled trial. 105 patients will be enrolled (35 in each group). Patients will be included in each of the two participating centers (Amiens, Caen). The analysis will be made in RSA D7 + 2, 6 months 1, 12 months 1 24 months 1. An assessment will be made to 3 years if the analysis requires it to 2 years.

Analysis of pictures will be centralized in Caen and performed with specific software after transferring images via a secure network.

Enrollment

82 patients

Sex

All

Ages

60 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients older men or women 60-75 years
  • with a primary or secondary osteoarthritis or osteonecrosis
  • having a functional disorder requiring the installation of a total hip prosthesis of primary

Exclusion criteria

  • patients aged 76 years or more
  • protected adults
  • resumption of PTH
  • cephalic prosthesis recovery or intermediate
  • resumption of cupules
  • primary or secondary malignant tumor of the hip

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

82 participants in 3 patient groups

mobility insert with tripod attachment (Novae E®)
Other group
Description:
mobility insert with tripod attachment (Novae E®)
Treatment:
Device: Novae E®
mobility insert with press fit pure (Sunfit®)
Other group
Description:
mobility insert with press fit pure (Sunfit®)
Treatment:
Device: Sunfit®
fixed insert (Quartz®).
Other group
Description:
fixed insert (Quartz®).
Treatment:
Device: Quartz®

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems